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Background: Excessive early inﬂammation after myocardial infarction (MI) is associated with poor outcomes.
However, an approach for suppressing this early inﬂammation has not been reported. We previously reported
that postconditioning with lactate-enriched blood (PCLeB) induced excellent microcirculation recovery in pa-
tients with acute MI. We therefore tested the hypothesis that early inﬂammation after MI could be suppressed
by PCLeB.
Methods and results:We treated 17 consecutive patients with ST-elevationMI using primary percutaneous inter-
vention with our modiﬁed postconditioning protocol within 12 h of onset. In this protocol, the duration of each
brief reperfusionwas prolonged from10 to 60 s in a stepwisemanner. Lactated Ringer's solution (20–30mL)was
injected directly into the culprit coronary artery at the end of each brief reperfusion, and the balloonwas quickly
inﬂated at the site of the lesion to trap lactate within the ischemicmyocardium. Each brief ischemic period lasted
60 s. After 7 cycles of balloon inﬂation and deﬂation, full reperfusion was performed; subsequently, stenting
was performed. C-reactive protein (CRP) levels were measured daily and the peak values within the ﬁrst
7 days post-admission were recorded. Peak CRP values were compared with those in matched control patients
with acute MI treated without postconditioning. In both groups, only patients with CRP values b0.3 mg/dL on
admission were included. Peak CRP values were signiﬁcantly lower in the postconditioned group (control
group vs. postconditioned group, 5.05 ± 4.85 vs. 1.66 ± 1.57 mg/dL; p b 0.01).
Conclusion: PCLeB may suppress early inﬂammation after MI.
© 2014 The Authors. PublishedbyElsevier Ireland Ltd. Open access under CC BY-NC-ND license.Introduction
Excessive early inﬂammation after myocardial infarction (MI) is
associated with adverse left ventricular remodeling [1,2] and poor
outcomes [3]. However, an approach that effectively suppresses early
post-MI inﬂammation during/after reperfusion therapy has not been
reported. We previously reported that ischemic postconditioning with
lactate-enriched blood (PCLeB) induced excellent microcirculation re-
covery in patients with acute MI [4,5]. This has not been demonstrated
in patients with acute MI treated with the original postconditioning
procedures [6].liability and freedom from bias
ama Municipal Hospital, 2460
apan. Tel.: +81 48 873 4111;
land Ltd. Open access under CC BY-NCThe protective effects of postconditioning are thought to result
from a delayed recovery from intracellular acidosis during the early
phase of reperfusion [7]. Therefore, our modiﬁed postconditioning
protocol was designed based on the assumption that prolonging
the delay in intracellular acidic recovery may increase the protective
effects of postconditioning. The improved microcirculation recovery
achieved by our approach is expected to induce a healthier healing
process in the reperfused ischemic myocardium. If this is true, exces-
sive inﬂammatory responses will not be evoked by reperfusion.
Therefore, we tested the hypothesis that early post-MI inﬂammation
can be suppressed by our modiﬁed postconditioning protocol.Methods
This matched case–control study was approved by the ethics review
boards of Tachikawa Hospital, Ota Memorial Hospital, and Kitasato
Institute Hospital; all study patients provided informed consent.-ND license.
Fig. 1.Overviewof the protocol for ischemic postconditioningwith lactate-enriched blood.
The duration of each brief reperfusion was prolonged from 10 to 60 s in a stepwise man-
ner. At the end of each brief reperfusion, lactatewas supplied by injecting lactated Ringer's
solution into the culprit coronary artery. Each brief ischemic period lasted 60 s. After 7 cy-
cles of balloon inﬂation and deﬂation, full reperfusion was performed; subsequently,
stenting was performed. LCA, left coronary artery; and RCA, right coronary artery.
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The inclusion criteriawere as follows: hospital admissionwithin 12 h
of a ﬁrst ST-elevation MI; a C-reactive protein (CRP) level b0.3 mg/dL
upon admission; no collagen-related diseases, malignancies, or any in-
fectious diseases; and eligibility for primary percutaneous coronary in-
tervention (PCI). An ST-elevation MI was deﬁned as prolonged chest
pain (duration, N30 min) and an ST-segment elevation N1 mm in ≥2
adjacent leads. Patients having an infarct-related coronary artery with
a Thrombolysis in Myocardial Infarction (TIMI) ﬂow grade II or III were
excluded from the study. The relevant patient characteristics are
shown in Table 1.
Study protocol
We treated 17 consecutive patients who met the inclusion criteria
with primary PCI using our modiﬁed postconditioning protocol
(Fig. 1). In this postconditioning protocol, the duration of each brief
reperfusion was prolonged from 10 to 60 s in a stepwise manner. This
approach sought to prevent rapid and abrupt washout of lactate during
the very early phase of reperfusion. At the end of each brief reperfusion,
lactate was supplied by injecting lactated Ringer's solution (Lactec
Injection, Otsuka Pharmaceutical, Tokyo, Japan), containing 28 mM
lactate, into the culprit coronary artery (20 mL for the right coronary
artery, 30 mL for the left coronary artery). To trap the lactate within
the ischemic myocardium, the balloon was quickly inﬂated with low
pressure at the site of the lesion. Each brief ischemic period lasted
60 s. This approach aimed to achieve controlled reperfusion with cellu-
lar oxygenation and minimal lactate washout from the cells. Lactate ac-
cumulation is generally accepted to be responsible for intracellular
acidosis during ischemia. Therefore, the delay in recovery from intracel-
lular acidosis, achieved by simple intermittent reperfusion, may be
increased through this approach. After 7 cycles of balloon inﬂation and
deﬂation, full reperfusion was performed; subsequently, stenting was
performed, and the PCI was completed. Thrombosuction was imple-
mented only after completion of the postconditioning protocol
and only in cases where it was deemed necessary. Follow-up coronary
angiography (CAG) was scheduled for each patient 6–9 months after
reperfusion therapy, unless the patient refused.
Biomarker measurement
As an indicator of inﬂammation, each patient's blood CRP level was
measured daily using a latex photometric immunoassay; the peak
value during the ﬁrst 7 days after admission was also recorded. Peak
CRP values were compared with those in control patients who experi-
enced ST-elevation MI and were successfully treated with primary PCI
without postconditioning. Data from control patients, treated before
2012 in our hospitals, were also collected within 12 h of MI onset.
Blood creatine kinase (CK) levels were measured every 3–4 h after ad-
mission until they peaked. In all control patients, stent implantationTable 1
Characteristics of control patients and postconditioned patients.
Control (n = 20
Age, years 65.4 ± 11.1
Male patients, n (%) 15 (75.0)
Patients with diabetes mellitus, n (%) 5 (25.0)
Time to reperfusion, h 5.7 ± 3.1
Peak CK value, IU/L 2336 ± 1143
Time from reperfusion to peak CK release, h 7.5 ± 4.4 (3–17
Proximal occlusion of a coronary artery⁎, n (%) 12 (60)
Proximal occlusion of LAD, n (%) 5 (25.0)
CK, creatine kinase; LAD, left anterior descending artery; PCLeB, postconditioning with lactate-
⁎ “Proximal occlusion of a coronary artery” includes occlusion of segments 1 and2 of the right
the left circumﬂex artery.was performed after balloon dilation of the culprit lesion. The control
patients were matched to the 17 study patients with respect to age,
gender, presence or absence of diabetes mellitus, time to reperfusion,
and peak CK values (Table 1). In the control group, only patients with
CRP values b0.3 mg/dL upon admission were included. Patients having
an infarct-related coronary arterywith a TIMI ﬂow of grade II or III were
not included in the control group. Patients with a collagen-related
disease, malignancy, or any infectious disease were also not included
in the control group.
Statistics
All continuous variables are reported as means ± SD. Differences
between continuous variables in the 2 patient groups were assessed
by a non-paired t-test. Categorical variables in the 2 groups were
compared using a chi-squared test or Fisher exact test. A p-value
b0.05 was considered statistically signiﬁcant.
Results
The 17 study patients were successfully reperfused, achieving a
grade III TIMIﬂowand a Blush grade ofmore than II. Markedmyocardial
staining with contrast medium and/or early visualization of venous
drainage on CAG were observed in each patient, indicating unimpaired
microcirculation. Figs. 2 and 3 show the ﬁnal CAG views from 2 repre-
sentative patients after completion of primary PCI. The ﬁgures also
show the CAG view of each patient in the chronic phase (6 months
after the MI), for comparison. In Fig. 2a, marked myocardial staining
with contrastmediumwas observed in theﬁnal CAG view after comple-
tion of PCI. The myocardium was stained more densely in the acute
phase than in the chronic phase (Fig. 2a and b, Videos 1 and 2). In
Fig. 3a, early visualization of venous drainage was observed after PCI
completion. Venous drainage was more clearly visualized in the) PCLeB (n = 17) p value
66.6 ± 14.3 NS
13 (76.5) NS
4 (23.5) NS
5.8 ± 3.9 NS
2370 ± 1042 NS




coronary artery, segments 6 and 7 of the left anterior descending artery, and segment 11 of
Fig. 2. Coronary angiography (CAG) of a representative patient before and after percutaneous coronary intervention (PCI). (a) Panel 0: CAG before PCI, showing total occlusion of the right
coronary artery. Panels 1–5: The ﬁnal CAG view after completion of stenting shown as a series of pictures. Markedmyocardial staining with contrast medium is observed throughout the
series (area surrounded by arrows). (b) CAG of the same patient 6 months later, shown as a series of pictures. Myocardial staining is not as dense as that during the acute phase.
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indicating facilitated drainage of the contrast medium through the mi-
crocirculation during the acute phase. Notably, the epicardial obtuse
marginal branch of the left circumﬂex coronary artery appeared more
spastic in the acute phase than in the chronic phase, despite the facilitated
venous drainage during the acute phase.
Fig. 4 shows a comparison of peak CRP levels between the PCLeB
group and thematched control group. Peak CRP levels were signiﬁcant-
ly lower in the PCLeB group than in thematched control group (control
group vs. postconditioned group, 5.05 ± 4.85 vs. 1.66 ± 1.57 mg/dL; p
b 0.01). This was despite similar peak CK levels between the 2 groups
and inclusion of a larger proportion of patients with proximal occlusion
of a coronary artery in the PCLeB group (Table 1). Notably, the time
from reperfusion to peak CK release was signiﬁcantly shorter in the
PCLeB group (range, 2–6 h) than in the control group (range, 3–17 h;
p b 0.01) (Table 1).Discussion
Our postconditioning approach consistently resulted in excellent
microcirculation recovery [4,5], and in some instances, produced coro-
nary blood ﬂow even better than that observed during the chronic
phase. One patient showed a constricted epicardial coronary artery
with facilitated venous drainage of the contrast medium (Fig. 3); this
ﬁnding suggests that locally produced endogenous vasodilating sub-
stances, instead of circulating or exogenous vasodilators, are responsi-
ble for the excellent, and sometimes supra-normal, microcirculation
recovery achieved.
Locally produced endogenous vasodilators such as adenosine or ni-
tric oxide are generally believed to be involved in the reactive hyper-
emia that is transiently observed immediately after reperfusion of an
ischemic myocardium. The reason for the transient nature of reactive
hyperemia is unknown. However, the ﬁndings of the present study
Fig. 3. Coronary angiography (CAG) of a second representative patient. (a) Panel 0: CAG before percutaneous coronary intervention (PCI), showing total occlusion of the left circumﬂex
artery. Panel 1: The ﬁnal CAG view after completion of stenting. Panel 2: Late phase of the ﬁnal CAG view; the obtuse marginal vein is clearly visualized (arrows). (b) CAG of the same
patient 6 months later. Panel 1: CAG in the early phase. Panel 2: The late phase of the same CAG view. The obtuse marginal vein looks blurred and is not as clearly visualized as that in
the acute phase, whereas the obtuse marginal artery is clearly dilated (arrows), as compared with that during the acute phase.
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crovascular reperfusion injury that occurs shortly after the initiation of
reactive hyperemia. If this is the case, prevention of reperfusion injury
would lead to the emergence of long-lasting reactive hyperemia,
unveiling the nature of the hyperemia. The exceptionally goodmicrocir-
culation recovery observed in patients treatedwith our protocolmay be
explained by this mechanism; other explanations are not apparent.
Myoﬁlaments lose their sensitivity to Ca2+ in the presence of
intracellular acidosis. The ischemic myocardium ceases contraction by
accumulating lactate to preserve adenosine triphosphate via this mech-
anism. Koyama et al. reported that simulated ischemia in guinea pig
myocytes resulted in reperfusion-induced contracture. This was accom-
panied by re-sensitization of the myoﬁlaments to Ca2+ resulting from
reperfusion-induced lactate washout [8]. An abrupt washout of lactate
by reperfusion may result in the development of hypercontracture,
with re-sensitization of themyoﬁlaments to Ca2+. Therefore, maintain-
ing a high concentration of intracellular lactate during early reperfusionFig. 4. Comparison of peak C-reactive protein levels between control patients and
postconditioned patients. CRP, C-reactive protein; PCLeB, postconditioning with lactate-
enriched blood.might prevent orminimize hypercontracture-inducedmyocardial dam-
age. Our modiﬁed protocol was designed to prevent lactate extrusion
from cells by maintaining high extracellular concentrations of lactate
during the early reperfusion period, thereby delaying the restoration
of vigorous contractile force. This proposed action is similar to cardiac
surgeons employing a potassium arrest during cardioprotective reper-
fusion, also called warm blood terminal cardioplegia. The strong force
generated by hypercontracture compresses the microcirculation,
thus obliterating coronary blood ﬂow. The excellent microcirculation
recovery achieved by our approach appears to provide good evidence
that our novel postconditioning approach successfully attenuates
reperfusion-induced hypercontracture.
Another ﬁnding suggestive of successful attenuation of reperfusion
injury by our approach is the very early peaking of serum CK release
consistently observed in the PCLeB group, irrespective of the time to
reperfusion. In patients treated with PCLeB, serum CK levels peaked
within 6 h of reperfusion therapy, without exception. Koyama et al. re-
ported a biphasic relationship between the time to reperfusion and the
time to peak CK release in patients who underwent successful PCI after
acute MI; the latest CK release occurred in patients treated approxi-
mately 7 h after the onset ofMI. Koyama et al. also showed a positive lin-
ear relationship between these 2 variables in patients treatedwithin 7 h
of onset and a negative linear relationship in patients treatedmore than
7 h after onset. The authors claimed that this biphasic relationship could
not be explained by the traditional, simple washout mechanism of CK,
but was explained after considering the signiﬁcant contribution of cell
death caused by reperfusion injury on early CK release [9]. In the present
study, this biphasic relationship between the time to reperfusion and
the time to peak CK release was not observed in patients treated with
PCLeB. This may be regarded as additional evidence for the successful
attenuation of reperfusion injury by PCLeB because the very early
peaking of CK release, irrespective of time to reperfusion, can be
explained simply by the traditional washout CK mechanism [10].
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thrombosuction. The original postconditioning protocol was intended
to prevent the formation of distal emboli by employing a direct stenting
procedure [6]. However, direct stenting is not always safe and is there-
fore not recommended for all patientswith acuteMI. Accordingly, phar-
macological postconditioning is currently being explored in an attempt
to avoid direct stenting. Unfortunately, the effectiveness of pharmaco-
logical postconditioning has not been proven in large-scale clinical
trials. Therefore, to avoid direct stenting, it is necessary to perform
either postconditioning or thrombosuction for reducing infarct size.
We chose to prioritize postconditioning over thrombosuction because
we believe that the amount of ischemic myocardium facing a risk of
lethal reperfusion injury was far larger than the amount of ischemic
myocardium that could not be salvaged because of the distal emboli
that could not be retrieved by thrombosuction after the postconditioning
procedures. In addition, inmany cases, thrombosuctionmay not result in
complete removal of all of the embolic materials, even when this proce-
dure is undertaken ﬁrst. Given the excellent microcirculation recovery
achieved by our approach, this postconditioning protocol appears to
surpass thrombosuction in terms of the restoration of microcirculatory
function. The basic concept of our postconditioning protocol is the main-
tenance of endogenous lactate inside the cells, thereby preventing rapid
restoration of contractile force upon reperfusion. If thrombosuction is
undertaken ﬁrst and uncontrollable coronary ﬂow recovery ensues, a
considerable amount of the lactate accumulated in the ischemic myocar-
dium would be washed away before the postconditioning procedures,
and vigorous myocardial contractile force would be quickly restored.
We believe that this sequence is hazardous to the reperfused myocardi-
um. The present postconditioning protocol prevented this sequence by
employing lactate as an inherent contractile activity blocker; this protocol
was prioritized over thrombosuction.
In the present study, peak CRP levels were signiﬁcantly lower in the
PCLeB group than in the matched control group. Because the mean
peak CK value in the PCLeB group was relatively low, only patients with
relatively small infarct sizes, estimated by the basis of peak CK values,
were included in the matched control group. In fact, signiﬁcantly fewer
patients had proximal occlusion of a coronary artery in thematched con-
trol group than in the PCLeB group. Nonetheless, a signiﬁcantly reduced
increase in CRP levels was observed in the PCLeB groups. Immediately
after MI, CRP levels are positively related to peak CK levels [2]; therefore,
the peak CRP levels in the matched control group should be lower than
those in patients with acute MI among the general population. In fact,
the peak CRP levels in the control patients were substantially lower
than those reported in the literature [1–3]. Accordingly, patients treated
with the modiﬁed postconditioning protocol were disadvantageously
compared with the control patients in terms of the severity of their
early inﬂammation after MI. Thus, the differences in the peak CRP levels
between the 2groups in this studywereprobably underestimated. There-
fore, despite the small and non-randomized nature of this study, the re-
sults obtained here should reﬂect the protective effect of this new
treatment strategy. This statementmay be supported by the other, afore-
mentioned ﬁndings in the present study, suggestive of successful attenu-
ation of reperfusion injury.
The present study had some limitations. First, it was a small-scale
study involving a limited number of patients. Despite the small-scale
nature of the study, the results appear to be promising. However, addi-
tional investigations involving a larger number of patients are required
to elucidate the true value of this new treatment strategy. Second, it was
not a randomized controlled trial involving prospectively enrolled
patients. As physicians, we found it difﬁcult not to treat patients
experiencing severe chest pain with our novel approach. We were
aware that patients with acute MI would achieve rapid relief with our
approach in terms of rapid resolution of their chest pain and scant seri-
ous reperfusion arrhythmias, as previously reported [4,5]. This would
result in safer subsequent procedures, along with maintaining the
patient in a better condition, both physically and mentally, during andafter the procedures. Furthermore,we believed that the consistently ob-
served, excellent microcirculation recovery achieved by our approach
might improve the long-term outcomes of the patients. Thus, we
could not justify, performing a randomized control trial, and therefore,
conducted a matched case-control study, instead. Third, we did not
compare the effects of our modiﬁed postconditioning protocol with
those of the original postconditioning protocol without lactate manipu-
lation. The excellent microcirculation recovery achieved by our ap-
proach has never been reported with the original postconditioning
procedures [6]. Moreover, the original postconditioning protocol
reportedly does not prevent the no-reﬂow phenomenon in animal
experiments [11]. Our approach has consistently shown excellent mi-
crocirculation recovery and occasionally, extremely good, microcircula-
tion recovery, which is in stark contrast to the no-reﬂow phenomenon.
Given the recent controversy regarding the protective effects of the
original postconditioning procedures [12,13], the beneﬁt of the
addition of lactate to the heart during the intermittent reperfusion
postconditioning seems apparent. In terms of the relevance of violent
environmental changes occurring inside the ischemic myocardium
upon reperfusion, the supplemental addition of lactate to the heart dur-
ing the intermittent reperfusion might be quite rational and possibly
crucial for myocardial protection. Given the safety aspects, especially
the absence of pharmacological side effects of lactated Ringer's solution,
we believe that injecting lactated Ringer's solution during the intermit-
tent reperfusion of thepostconditioningprocedures isworthwhile, even
in the absence of any direct comparative evidence.
In conclusion, ischemic postconditioning with lactate-enriched
blood may suppress early inﬂammation after MI. However, further
investigations involving a larger number of patients are needed to
examine the true value of this new approach for treating patient with
acute MI.





[1] Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct
expansion and cardiac rupture after a ﬁrst Q-wave acute myocardial infarction.
Circulation 1997;96:778–84.
[2] Anzai T. Post-infarction inﬂammation and left ventricular remodeling—a double-
edged sword. Circ J 2013;77:580–7.
[3] Suleiman M, Khatib R, Agmon Y, et al. Early inﬂammation and risk of long-term
development of heart failure and mortality in survivors of acute myocardial infarc-
tion predictive role of C-reactive protein. J Am Coll Cardiol 2006;47:962–8.
[4] Koyama T, Baba A, ShibataM,Moritani K, ShimadaM, AkaishiM. Postconditioningwith
lactate-enriched blood potentiates the protective effect of postconditioning alone in
patients with acute myocardial infarction. Circulation 2012;126:A9512 [(Abstract)].
[5] Koyama T, Masaru S, Moritani K. Ischemic postconditioning with lactate-enriched
blood in patients with acute myocardial infarction. Cardiology 2013;125:92–3.
[6] Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation
2005;112:2143–8.
[7] Inserte J, Barba I, Hernando V, Garcia-Dorado D. Delayed recovery of intracellular
acidosis during reperfusion prevents calpain activation and determines protection
in postconditioned myocardium. Cardiovasc Res 2009;81:116–22.
[8] Koyama T, Temma K, Akera T. Reperfusion-induced contracture develops with a
decreasing [Ca2+]i in single heart cells. Am J Physiol Heart Circ Physiol 1991;261:
H1115–22.
[9] Koyama T, Shimada M, Baba A, Kosugi R, Akaishi M. Effects of early reperfusion on
creatine kinase release in patients with acute myocardial infarction: implications
for reperfusion injury. Int J Cardiol 2012;155:335–7.
[10] Apple FS. Diagnostic use of CK-MM and CK-MB isoforms for detecting myocardial
infarction. Clin Lab Med 1989;4:643–54.
[11] Hale SL, Mehra A, Leeka J, Kloner RA. Postconditioning fails to improve no reﬂow or
alter infarct size in an open-chest rabbit model of myocardial ischemia–reperfusion.
Am J Physiol Heart Circ Physiol 2008;294:H421–5.
[12] Freixa X, Bellera N, Ortiz-Pérez JT, et al. Ischaemic postconditioning revisited: lack of
effects on infarct size following primary percutaneous coronary intervention. Eur
Heart J 2012;33:103–12.
[13] Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact
or ﬁction? Eur Heart J 2012;33:13–5.
